Tánczos, B., Vass, V., Szabó, E., Lovas, M., Kattoub, R., Bereczki, I., Borbás, A., Herczegh, P., Tósaki, Á.: Effects of H2S-donor ascorbic acid derivative and ischemia/reperfusion-induced injury in isolated rat hearts.
Eur. J. Pharm. Sci. 195 1-15, 2024.

Szőke, K., Bódi, B., Hendrik, Z., Czompa, A., Gyöngyösi, A., Haines, D., Papp, Z., Tósaki, Á., Lekli, I.: Rapamycin treatment increases survival, autophagy biomarkers and expression of the anti-aging klotho protein in elderly mice.
Pharmacol. Res. & Perspec. 11 (3), 1-11, 2023.

Vass, V., Szabó, E., Bereczki, I., Debreczeni, N., Borbás, A., Herczegh, P., Tósaki, Á.: Reperfusion-induced injury and the effects of the dithioacetate type hydrogen sulfide donor ibuprofen derivative, BM-88, in isolated rat hearts.
Eur. J. Pharm. Sci. 185 1-14, 2023.

Csépányi, E., Gyöngyösi, A., Lekli, I., Tósaki, Á., Bak, I.: Beta-Carotene Affects the Effects of Heme Oxygenase-1 in Isolated, Ischemic/Reperfused Rat Hearts: potential Role of the Iron.
Molecules. 27 (9), 1-12, 2022.

Gyöngyösi, A., Verner, V., Bereczki, I., Kiss-Szikszai, A., Zilinyi, R., Tósaki, Á., Bak, I., Borbás, A., Herczegh, P., Lekli, I.: Basic Pharmacological Characterization of EV-34, a New H2S-Releasing Ibuprofen Derivative.
Molecules. 26 (3), 1-12, 2021.

Tósaki, Á.: ArrhythmoGenoPharmacoTherapy.
Front. Pharmacol. 11 1-19, 2020.

Haines, D., Tósaki, Á.: Heme Degradation in Pathophysiology of and Countermeasures to Inflammation-Associated Disease.
Int. J. Mol. Sci. 21 (24), 1-25, 2020.

Szőke, K., Czompa, A., Lekli, I., Szabados-Fürjesi, P., Herczeg, M., Csávás, M., Borbás, A., Herczegh, P., Tósaki, Á.: A new, vasoactive hybrid aspirin containing nitrogen monoxide-releasing molsidomine moiety.
Eur. J. Pharm. Sci. 131 159-166, 2019.

Szőke, K., Czompa, A., Lekli, I., Szabados-Fürjesi, P., Herczeg, M., Csávás, M., Borbás, A., Herczegh, P., Tósaki, Á.: Dataset on structure, stability and myocardial effects of a new hybrid aspirin containing nitrogen monoxide-releasing molsidomine moiety.
Data brief. 25 1-10, 2019.

Czeglédi, A., Tósaki, Á., Gyöngyösi, A., Zilinyi, R., Tósaki, Á., Lekli, I.: Electrically-Induced Ventricular Fibrillation Alters Cardiovascular Function and Expression of Apoptotic and Autophagic Proteins in Rat Hearts.
Int. J. Mol. Sci. 20 (7), 1-12, 2019.

Gyöngyösi, A., Szőke, K., Fenyvesi, F., Fejes, Z., Bekéné Debreceni, I., Nagy, B., Tósaki, Á., Lekli, I.: Inhibited autophagy may contribute to heme toxicity in cardiomyoblast cells.
Biochem. Biophys. Res. Commun. 511 (4), 732-738, 2019.

Gyöngyösi, A., Zilinyi, R., Czeglédi, A., Tósaki, Á., Tósaki, Á., Lekli, I.: The role of autophagy and death pathways in dose-dependent isoproterenol-induced cardiotoxicity.
Curr. Pharm. Design. 25 (19), 2192-2198, 2019.

Czompa, A., Szőke, K., Prokisch, J., Gyöngyösi, A., Bak, I., Balla, G., Tósaki, Á., Lekli, I.: Aged (Black) versus Raw Garlic against Ischemia/Reperfusion-Induced Cardiac Complications.
Int. J. Mol. Sci. 19 (4), 1-13, 2018.

Haines, D., Tósaki, Á.: Emerging Clinical Applications of Heme Oxygenase.
Curr. Pharm. Design. 24 (20), 2227-2228, 2018.

Barta, T., Tósaki, Á., Haines, D., Balla, G., Lekli, I., Tósaki, Á.: Endothelin-1-induced hypertrophic alterations and heme oxygenase-1 expression in cardiomyoblasts are counteracted by beta estradiol: in vitro and in vivo studies.
Naunyn-Schmiedebergs Arch. Pharmacol. 391 (4), 371-383, 2018.

Haines, D., Tósaki, Á.: Role of Heme Oxygenases in Cardiovascular Syndromes and Co-morbidities.
Curr. Pharm. Design. 24 (20), 2322-2325, 2018.

Szabados-Fürjesi, P., Pajtás, D., Barta, A., Csépányi, E., Kiss-Szikszai, A., Tósaki, Á., Bak, I.: Synthesis, in Vitro Biological Evaluation, and Oxidative Transformation of New Flavonol Derivatives: The Possible Role of the Phenyl-N,N-Dimethylamino Group.
Molecules. 23 (12), 1-15, 2018.

Zilinyi, R., Czompa, A., Czeglédi, A., Gajtkó, A., Pituk, D., Lekli, I., Tósaki, Á.: The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: the Role of Autophagy.
Molecules. 23 (5), 1-12, 2018.

Csépányi, E., Czompa, A., Szabados-Fürjesi, P., Lekli, I., Balla, J., Balla, G., Tósaki, Á., Bak, I.: The Effects of Long-Term, Low- and High-Dose Beta-Carotene Treatment in Zucker Diabetic Fatty Rats: the Role of HO-1.
Int. J. Mol. Sci. 19 (4), 1-13, 2018.

Gyöngyösi, A., Terraneo, L., Bianciardi, P., Tósaki, Á., Lekli, I., Samaja, M.: The Impact of Moderate Chronic Hypoxia and Hyperoxia on the Level of Apoptotic and Autophagic Proteins in Myocardial Tissue.
Oxidative Medicine and Cellular Longevity. 2018 1-12, 2018.

Vecsernyés, M., Szokol, M., Bombicz, M., Priksz, D., Gesztelyi, R., Fülöp, G., Varga, B., Juhász, B., Haines, D., Tósaki, Á.: Alpha-Melanocyte-stimulating Hormone Induces Vasodilation and Exerts Cardioprotection Through the Heme-Oxygenase Pathway in Rat Hearts.
J. Cardiovasc. Pharmacol. 69 (5), 286-297, 2017.

Csépányi, E., Szabados-Fürjesi, P., Kiss-Szikszai, A., Frensemeier, L., Karst, U., Lekli, I., Haines, D., Tósaki, Á., Bak, I.: Antioxidant Properties and Oxidative Transformation of Different Chromone Derivatives.
Molecules. 22 (4), 1-12, 2017.

Lekli, I., Haines, D., Balla, G., Tósaki, Á.: Autophagy: an adaptive physiologic countermeasure to cellular senescence and ischemia/reperfusion-associated cardiac arrhythmias.
J. Cell. Mol. Med. 21 (6), 1058-1072, 2017.

Czompa, A., Gyöngyösi, A., Szőke, K., Bak, I., Csépányi, E., Haines, D., Tósaki, Á., Lekli, I.: Effects of Momordica charantia (Bitter Melon) on Ischemic Diabetic Myocardium.
Molecules. 22 (3), 488, 2017.

Csépányi, E., Czompa, A., Haines, D., Lekli, I., Bakondi, E., Balla, G., Tósaki, Á., Bak, I.: Cardiovascular effects of low versus high-dose beta-carotene in a rat model.
Pharmacol. Res. 100 148-156, 2015.

Papp-Bata, Á., Csiki, Z., Tósaki, Á., Szakály, Z.: Meggymag kivonat - egy új termék a funkcionális élelmiszerek piacán?.
Táplálkozásmarketing. 2 (1), 31-34, 2015.

Csiki, Z., Papp-Bata, Á., Czompa, A., Nagy, A., Bak, I., Lekli, I., Jávor, A., Haines, D., Balla, G., Tósaki, Á.: Orally delivered sour cherry seed extract (SCSE) affects cardiovascular and hematological parameters in humans.
Phytother. Res. 29 (3), 444-449, 2015.

Pák, K., Papp, C., Galajda, Z., Szerafin, T., Varga, B., Juhász, B., Haines, D., Szentmiklósi, J., Tósaki, Á., Gesztelyi, R.: Approximation of A1 adenosine receptor reserve appertaining to the direct negative inotropic effect of adenosine in hyperthyroid guinea pig left atria.
Gen. Physiol. Biophys. 33 (2), 177-188, 2014.

Czompa, A., Gyöngyösi, A., Czeglédi, A., Csépányi, E., Bak, I., Haines, D., Tósaki, Á., Lekli, I.: Cardioprotection afforded by sour cherry seed kernel: the role of heme oxygenase-1.
J. Cardiovasc. Pharmacol. 64 (5), 412-419, 2014.

Czompa, A., Nagy, A., Bak, I., Hendrik, Z., Lekli, I., Csiki, Z., Tósaki, Á.: Consumer investigation and toxicological analysis of sour cherry seed kernel extract.
Acta Physiol. 211 (Suppl), 84, 2014.

Kertész, A., Bombicz, M., Priksz, D., Balla, J., Balla, G., Gesztelyi, R., Varga, B., Haines, D., Tósaki, Á., Juhász, B.: Adverse Impact of Diet-Induced Hypercholesterolemia on Cardiovascular Tissue Homeostasis in a Rabbit Model: time-Dependent Changes in Cardiac Parameters.
Int. J. Mol. Sci. 14 (9), 19086-19108, 2013.

Juhász, B., Haines, D., Tósaki, Á.: Aging: oxidative stress and senescent cellular phenotypes.
In: Adaptation biology and medicine. Eds.: Laurentiu M. Popescu, Alan R. Hargens, Pawan K. Signal, Narosa Publishing House, New Delhi, 469-481, 2013. ISBN: 9788184872149

Juhász, B., Kertész, A., Balla, J., Balla, G., Szabó, Z., Bombicz, M., Priksz, D., Gesztelyi, R., Varga, B., Haines, D., Tósaki, Á.: Cardioprotective Effects of Sour Cherry Seed Extract (SCSE) on the Hypercholesterolemic Rabbit Heart.
Curr. Pharm. Design. 19 (39), 6896-6905, 2013.

Haines, D., Juhász, B., Tósaki, Á.: Management of multicellular senescence and oxidative stress.
J. Cell. Mol. Med. 17 (8), 936-957, 2013.

Tósaki, Á.: Pharmacological mechanisms and interventions in ischemia/ reperfusion-induced injury.
Curr. Phar. Des. 19 (39), 6839-6841, 2013.

Varga, B., Gesztelyi, R., Bombicz, M., Haines, D., Szabó, A., Kemény-Beke, Á., Antal, M., Vecsernyés, M., Juhász, B., Tósaki, Á.: Protective Effect of Alpha-Melanocyte-Stimulating Hormone (α-MSH) on the Recovery of Ischemia/Reperfusion (I/R)-Induced Retinal Damage in A Rat Model.
J. Mol. Neurosci. 50 (3), 558-570, 2013.

Mahmoud, F., Al-Awadhi, R., Haines, D., Dashti, A., Dashti, H., Al, -., Bak, I., Tósaki, Á.: Sour Cherry Seed Kernel Extract Increases Heme Oxygenase-1 Expression and Decreases Representation of CD3+ TNF-[alfa] + and CD3+ IL-8+ Subpopulations in Peripheral Blood Leukocyte Cultures from Type 2 Diabetes Patients.
Phytother. Res. 27 (5), 767-774, 2013.

Meyer, G., Czompa, A., Reboul, C., Csépányi, E., Czeglédi, A., Bak, I., Balla, G., Balla, J., Tósaki, Á., Lekli, I.: The Cellular Autophagy Markers Beclin-1 and LC3B-II are Increased during Reperfusion in Fibrillated Mouse Hearts.
Curr. Pharm. Des. 19 (39), 6912-6918, 2013.

Kiss, Z., Pák, K., Zsuga, J., Juhász, B., Varga, B., Szentmiklósi, J., Haines, D., Tósaki, Á., Gesztelyi, R.: The guinea pig atrial A1 adenosine receptor reserve for the direct negative inotropic effect of adenosine.
Gen. Physiol. Biophys. 32 (3), 325-335, 2013.

Gesztelyi, R., Kiss, Z., Wachal, Z., Juhász, B., Bombicz, M., Csépányi, E., Pák, K., Zsuga, J., Papp, C., Galajda, Z., Branzaniuc, K., Pórszász, R., Szentmiklósi, J., Tósaki, Á.: The surmountable effect of FSCPX, an irreversible A1 adenosine receptor antagonist, on the negative inotropic action of A1 adenosine receptor full agonists in isolated guinea pig left atria.
Arch. Pharm. Res. 36 (3), 293-305, 2013.

Kalantari, H., Galehdari, H., Zaree, Z., Gesztelyi, R., Varga, B., Haines, D., Bombicz, M., Tósaki, Á., Juhász, B.: Toxicological and mutagenic analysis of Artemisia dracunculus (tarragon) extract.
Food Chem. Toxicol. 51 26-32, 2013.

Oros, M., Zavaczki, E., Vadász, C., Jeney, V., Tósaki, Á., Lekli, I., Balla, G., Nagy, L., Balla, J.: Ethanol increases phosphate-mediated mineralization and osteoblastic transformation of vascular smooth muscle cells.
J. Cell. Mol. Med. 16 (9), 2219-2226, 2012.

Mahmoud, F., Haines, D., Al-Awadhi, R., Arifhodzic, N., Abal, A., Azeamouzi, C., Al-Sharah, S., Tósaki, Á.: In vitro suppression of lymphocyte activation in patients with seasonal allergic rhinitis and pollen-related asthma by citirizene or azelastine in combination with ginkgolide B or astaxanthin.
Acta Physiol. Hung. 99 (2), 173-184, 2012.

Haines, D., Lekli, I., Teissier, P., Bak, I., Tósaki, Á.: Role of haeme oxygenase-1 in resolution of oxidative stress-related pathologies: focus on cardiovascular, lung, neurological and kidney disorders.
Acta Physiol. 204 (4), 487-501, 2012.

Gesztelyi, R., Zsuga, J., Kemény-Beke, Á., Varga, B., Juhász, B., Tósaki, Á.: The Hill equation and the origin of quantitative pharmacology.
Arch. Hist. Exact Sci. 66 (4), 427-438, 2012.

Gesztelyi, R., Kiss, Z., Zsuga, J., Pák, K., Papp, C., Galajda, Z., Branzaniuc, K., Szentmiklósi, J., Tósaki, Á.: Thyroid hormones decrease the affinity of 8-cyclopentyl-1,3-dipropylxanthine (CPX), a competitive antagonist, for the guinea pig atrial A(1) adenosine receptor.
Gen. Physiol. Biophys. 31 (4), 389-400, 2012.

Tósaki, Á.: A gyógyszerhatástan válogatott fejezetei.
Debreceni Egyetem, Debrecen, 314 p., 2011.

Aigner, Z., Bácskay, I., Blazsó, G., Botz, L., Dévay, A., Doró, P., Dredán, J., Fehér, P., Fenyvesi, F., Gáspár, R., Gunda, T., Hajdú, Z., Halmos, G., Herczegh, P., Hohmann, J., Lázár, L., Liktor-Busa, E., Nagymajtényi, L., Pál, S., Pálfi, M., Perjési, P., Soós, G., Szökő, É., Takács-Novák, K., Tábi, T., Tósaki, Á., Tóthfalusi, L., Zelkó, R., Zupkó, I., Váradi, J., Veres, K.: Általános gyógyszerészeti ismeretek.
Medicina Könyvkiadó Zrt., Budapest, 496 p., 2011. ISBN: 9789632429441

Petrovski, G., Das, S., Juhász, B., Kertész, A., Tósaki, Á., Das, D.: Cardioprotection by endoplasmic reticulum stress-induced autophagy.
Antioxid. Redox Signal. 14 (11), 2191-2200, 2011.

Bak, I., Czompa, A., Csépányi, E., Juhász, B., Kalantari, H., Najm, K., Aghel, N., Varga, B., Haines, D., Tósaki, Á.: Evaluation of systemic and dermal toxicity and dermal photoprotection by sour cherry kernels.
Phytother. Res. 25 (11), 1714-1720, 2011.

Galajda, Z., Balla, J., Szentmiklósi, J., Bíró, T., Czifra, G., Dobrosi, N., Cseppentő, Á., Patonay, L., Röszer, T., Balla, G., Popescu, L., Lekli, I., Tósaki, Á.: Histamine and H1-Histamine receptors faster venous circulation.
J. Cell. Mol. Med. 15 (12), 2614-2623, 2011.

Moro, C., Grauzam, S., Ormezzano, O., Toufektsian, M., Tanguy, S., Calabrese, P., Coll, J., Bak, I., Juhász, B., Tósaki, Á., de Leiris, J., Boucher, F.: Inhibition of cardiac leptin expression after infarction reduces subsequent dysfunction.
J. Cell. Mol. Med. 15 (8), 1688-1694, 2011.

Varga, B., Szabadfi, K., Kiss, P., Fábián, E., Tamás, A., Griecs, M., Gabriel, R., Reglődi, D., Kemény-Beke, Á., Pamer, Z., Biró, Z., Tósaki, Á., Atlasz, T., Juhász, B.: PACAP improves functional outcome in excitotoxic retinal lesion: an electroretinographic study.
J. Mol. Neurosci. 43 (1), 44-50, 2011.

Juhász, B., Varga, B., Czompa, A., Bak, I., Lekli, I., Gesztelyi, R., Zsuga, J., Kemény-Beke, Á., Antal, M., Szendrei, L., Tósaki, Á.: Postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium.
J. Cell. Mol. Med. 15 (9), 1973-1982, 2011.

Kalantari, H., Jalali, M., Jalali, A., Mahdavinia, M., Salimi, A., Juhász, B., Tósaki, Á., Gesztelyi, R.: Protective effect of Cassia fistula fruit extract against bromobenzene-induced liver injury in mice.
Hum. Exp. Toxicol. 30 (8), 1039-1044, 2011.

Kalantari, H., Jalali, M., Jalali, A., Salimi, A., Alhalvachi, F., Varga, B., Juhász, B., Jakab, A., Kemény-Beke, Á., Gesztelyi, R., Tósaki, Á., Zsuga, J.: Protective effect of Cassia fistula fruit extract on bromobenzene-induced nephrotoxicity in mice.
Hum. Exp. Toxicol. 30 (10), 1710-1715, 2011.

Fenyvesi, F., Kiss, T., Fenyvesi, É., Szente, L., Veszelka, S., Deli, M., Váradi, J., Fehér, P., Ujhelyi, Z., Tósaki, Á., Vecsernyés, M., Bácskay, I.: Randomly Methylated beta-Cyclodextrin Derivatives Enhance Taxol Permeability Through Human Intestinal Epithelial Caco-2 Cell Monolayer.
J. Pharm. Sci. 100 (11), 4734-4744, 2011.

Tósaki, Á.: Selected Chapters of Pharmacology.
Debreceni Egyetem, Debrecen, 146 p., 2011.

Haines, D., Varga, B., Bak, I., Juhász, B., Mahmoud, F., Kalantari, H., Gesztelyi, R., Lekli, I., Czompa, A., Tósaki, Á.: Summative interaction between astaxanthin, Ginkgo biloba extract (EGb761) and vitamin C in Suppression of respiratory inflammation: a comparison with ibuprofen.
Phytother. Res. 25 (1), 128-136, 2011.

Lekli, I., Ray, D., Mukherjee, S., Gurusamy, N., Ahsan, M., Juhász, B., Bak, I., Tósaki, Á., Gherghiceanu, M., Popescu, L., Das, D.: Co-ordinated autophagy with resveratrol and gamma-tocotrienol confers synergetic cardioprotection.
J. Cell. Mol. Med. 14 (10), 2506-2518, 2010.

Grenczer, M., Zsuga, J., Majoros, L., Pintér, Á., Kemény-Beke, Á., Juhász, B., Tósaki, Á., Gesztelyi, R.: Effect of asymmetry of concentration-response curves on the results obtained by the receptorial responsiveness method (RRM): an in silico study.
Can. J. Physiol. Pharmacol. 88 (11), 1074-1083, 2010.

Mukherjee, S., Ray, D., Lekli, I., Bak, I., Tósaki, Á., Das, D.: Effects of Longevinex (modified resveratrol) on cardioprotection and its mechanisms of action.
Can. J. Physiol. Pharmacol. 88 (11), 1017-1025, 2010.

Kiss, T., Fenyvesi, F., Bácskay, I., Váradi, J., Fenyvesi, É., Iványi, R., Szente, L., Tósaki, Á., Vecsernyés, M.: Evaluation of the cytotoxicity of beta-cyclodextrin derivatives: evidence for the role of cholesterol extraction.
Eur. J. Pharm. Sci. 40 (4), 376-380, 2010.

Lekli, I., Mukherjee, S., Ray, D., Gurusamy, N., Kim, Y., Tósaki, Á., Engelman, R., Ho, Y., Das, D.: Functional recovery of diabetic mouse hearts by glutaredoxin-1 gene therapy: role of Akt-FoxO-signaling network.
Gene Ther. 17 (4), 478-485, 2010.

Bak, I., Lekli, I., Juhász, B., Varga, E., Varga, B., Gesztelyi, R., Szendrei, L., Tósaki, Á.: Isolation and Analysis of Bioactive Constituents of Sour Cherry (Prunus cerasus) Seed Kernel: an Emerging Functional Food.
J. Med. Food. 13 (4), 905-910, 2010.

Bak, I., Czompa, A., Juhász, B., Lekli, I., Tósaki, Á.: Reduction of reperfusion-induced ventricular fibrillation and infarct size via heme oxygenase-1 overexpression in isolated mouse hearts.
J. Cell. Mol. Med. 14 (9), 2268-2272, 2010.

Juhász, B., Varga, B., Gesztelyi, R., Kemény-Beke, Á., Zsuga, J., Tósaki, Á.: Resveratrol: a multifunctional cytoprotective molecule.
Curr. Pharm. Biotechnol. 11 (8), 810-818, 2010.

Grenczer, M., Pintér, Á., Zsuga, J., Kemény-Beke, Á., Juhász, B., Szodoray, P., Tósaki, Á., Gesztelyi, R.: The influence of affinity, efficacy, and slope factor on the estimates obtained by the receptorial responsiveness method (RRM): a computer simulation study.
Can. J. Physiol. Pharmacol. 88 (11), 1061-1073, 2010.

Lekli, I., Tósaki, Á.: Új irányvonalak a betegségek kezelésében a XXI-ik században: redox fehérjék lehetséges génterápiás alkalmazása.
Motesz Mag. 18 (4), 17-22, 2010.

Lekli, I., Gurusamy, N., Ray, D., Tósaki, Á., Das, D.: Redox regulation of stem cell mobilization.
Can. J. Physiol. Pharmacol. 87 (12), 989-995, 2009.

Juhász, B., Gesztelyi, R., Tósaki, Á.: Some useful methods for the detection of redox signaling in various organs.
In: Methods in redox signaling. Ed.: Das, Dipak K, Mary Ann Liebert, New York, 163-172, 2009.

Brown, L., Kroon, P., Das, D., Das, S., Tósaki, Á., Chan, V., Singer, M., Feick, P.: The biological responses to resveratrol and other polyphenols from alcoholic beverages.
Alcoholism Clin. Exp. Res. 33 (9), 1513-1523, 2009.

Hertelendi, Z., Tóth, A., Borbély, A., Galajda, Z., Édes, I., Tósaki, Á., Papp, Z.: The peroxynitrite evoked contractile depression can be partially reversed by antioxidants in human cardiomyocytes.
J. Cell. Mol. Med. 13 (8B), 2200-2209, 2009.

Lekli, I., Das, S., Das, S., Mukherjee, S., Bak, I., Juhász, B., Baghci, D., Trimurtulu, G., Krishnaraju, A., Sengupta, K., Tósaki, Á., Das, D.: Coenzyme Q9 provides cardioprotection after converting into coenzyme Q10.
J. Agric. Food Chem. 56 (13), 5331-5337, 2008.

Nagy, N., Malik, G., Tósaki, Á., Ho, Y., Maulik, N., Das, D.: Overexpression of glutaredoxin-2 reduces myocardial cell death by preventing both apoptosis and necrosis.
J. Mol. Cell. Cardiol. 44 (2), 252-260, 2008.

Lekli, I., Szabó, G., Juhász, B., Das, S., Das, M., Varga, E., Szendrei, L., Gesztelyi, R., Váradi, J., Bak, I., Das, D., Tósaki, Á.: Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin.
Am. J. Physiol. Heart Circ. Physiol. 294 H859-H866, 2008.

Juhász, B., Dér, P., Szodoray, P., Gesztelyi, R., Lekli, I., Bak, I., Antal, M., Maulik, N., Tósaki, Á., Vecsernyés, M.: Adrenocorticotrope hormone fragment (4-l0) attenuates the ischemia/reperfusion-induced cardiac injury in isolated rat hearts.
Antioxid. Redox Signal. 9 (11), 1851-1861, 2007.

Tósaki, Á.: A gyógyszerhatástan válogatott fejezetei.
Debreceni Egyetem, Debrecen, 294 p., 2007.

Váradi, J., Lekli, I., Juhász, B., Bácskay, I., Szabó, G., Gesztelyi, R., Szendrei, L., Varga, E., Bak, I., Foresti, R., Motterlini, R., Tósaki, Á.: Beneficial effects of carbon monoxide-releasing molecules on post-ischemic myocardial recovery.
Life Sci. 80 (17), 1619-1626, 2007.

Moro, C., Jouan, M., Rakotovao, A., Toufektsian, M., Ormezzano, O., Nagy, N., Tósaki, Á., de Leiris, J., Boucher, F.: Delayed expression of cytokines after reperfused myocardial infarction: possible trigger for cardiac dysfunction and ventricular remodeling.
Am. J. Physiol. Heart Circ. Physiol. 293 (5), H3014-H3019, 2007.

Karsai, D., Gesztelyi, R., Zsuga, J., Jakab, A., Szendrei, L., Juhász, B., Bak, I., Szabó, G., Lekli, I., Vecsernyés, M., Varga, E., Szentmiklósi, J., Tósaki, Á.: Influence of hyperthyroidism on the effect of adenosine transport blockade assessed by a novel method in guinea pig atria.
Cell. Biochem. Biophys. 47 (1), 45-52, 2007.

Nagy, N., Shiroto, K., Malik, G., Huang, C., Gaestel, M., Abdellatif, M., Tósaki, Á., Maulik, N., Das, D.: Ischemic preconditioning involves dual cardio-protective axes with p38MAPK as upstream target.
J. Mol. Cell. Cardiol. 42 (5), 981-990, 2007.

Tósaki, Á., Das, S., Das, D.: Resveratrol miracle: prevention against a wide spectrum of diseases.
J. Sci. Technol. Tropics. 3 81-95, 2007.

Thirunavukkarasu, M., Juhász, B., Zhan, L., Menon, V., Tósaki, Á., Otani, H., Maulik, N.: VEGFR1 (Flt-1+/-) gene knockout leads to the disruption of VEGF-mediated signaling through the nitric oxide/heme oxygenase pathway in ischemic preconditioned myocardium.
Free Radic. Biol. Med. 42 (10), 1487-1495, 2007.

Bak, I., Lekli, I., Juhász, B., Nagy, N., Varga, E., Váradi, J., Gesztelyi, R., Szabó, G., Szendrei, L., Bácskay, I., Vecsernyés, M., Antal, M., Fésüs, L., Boucher, F., de Leiris, J., Tósaki, Á.: Cardioprotective mechanisms of Prunus cerasus (sour cherry) seed extract against ischemia-reperfusion-induced damage in isolated rat hearts.
Am. J. Physiol.-Heart Circul. Physiol. 291 (3), H1329-H1336, 2006.

Karsai, D., Zsuga, J., Juhász, B., Dér, P., Szentmiklósi, J., Tósaki, Á., Gesztelyi, R.: Effect of nucleoside transport blockade on the Interstitial adenosine level characterized by a novel method in guinea pig atria.
J. Cardiovasc. Pharmacol. 47 (1), 103-109, 2006.

Das, S., Tósaki, Á., Bagchi, D., Maulik, N., Das, D.: Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling.
J. Pharmacol. Exp. Ther. 317 (3), 980-988, 2006.

Tósaki, Á., Édes, I.: The role of peroxiredoxins in ischemia-reperfusion-induced cardiac damage.
Am. J. Physiol.-Heart Circul. Physiol. 291 (6), H2586-H2587, 2006.

Szondy, Z., Mastroberardino, P., Váradi, J., Farrace, M., Nagy, N., Bak, I., Viti, I., Wieckowski, M., Melino, G., Rizzuto, R., Tósaki, Á., Fésüs, L., Piacentini, M.: Tissue transglutaminase (TG2) protects cardiomyocytes against ischemia/reperfusion injury by regulating ATP synthesis.
Cell Death Differ. 13 (10), 1827-1829, 2006.

Das, S., Tósaki, Á., Bagchi, D., Maulik, N., Das, D.: Resveratrol-Mediated Activation of cAMP Response Element-Binding Protein through Adenosine A3 Receptor by Akt-Dependent and -Independent Pathways.
J. Pharmacol. Exp. Ther. 314 (2), 762-769, 2005.

Rakotovao, A., Tanguy, S., Toufektsian, M., Berthonneche, C., Ducros, V., Tósaki, Á., de Leiris, J., Boucher, F.: Selenium status as determinant of connexin-43 dephosphorylation in ex vivo ischemic/reperfused rat myocardium.
J. Trace Elem. Med. Biol. 19 (1), 43-47, 2005.

Bak, I., Váradi, J., Nagy, N., Vecsernyés, M., Tósaki, Á.: The role of exogenous carbon monoxide in the recovery of post-ischemic cardiac function in buffer perfused isolated rat hearts.
Cell. Mol. Biol. 51 (5), 453-459, 2005.

Szilágyi, S., Pollesello, P., Levijoki, J., Haikala, H., Bak, I., Tósaki, Á., Borbély, A., Édes, I., Papp, Z.: Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone.
J. Cardiovasc. Pharmacol. 46 (3), 369-376, 2005.

Szabó, M., Gallyas, É., Bak, I., Rakotovao, A., Boucher, F., de Leiris, J., Nagy, N., Varga, E., Tósaki, Á.: Heme oxygenase-1-related carbon monoxide and flavonoids in ischemic/reperfused rat retina.
Invest. Ophthalmol. Vis. Sci. 45 (10), 3727-3732, 2004.

Varga, E., Nagy, N., Lázár, J., Czifra, G., Bak, I., Bíró, T., Tósaki, Á.: Inhibition of ischemia/reperfusion-induced damage by dexamethasone in isolated working rat hearts: the role of cytochrome c release.
Life Sci. 75 (20), 2411-2423, 2004.

Juhász, B., Dér, P., Turóczi, T., Bácskay, I., Varga, E., Tósaki, Á.: Preconditioning in Intact and Previously Diseased Myocardium: laboratory or Clinical Dilemma?.
Antioxid. Redox Signal. 6 (2), 325-333, 2004.

Tanguy, S., Morel, S., Berthonneche, C., Toufektsian, M., Lorgeril, M., Ducros, V., Tósaki, Á., de Leiris, J., Boucher, F.: Preischemic selenium status as a major determinant of myocardial infarct size in vivo in rats.
Antioxid. Redox Signal. 6 (4), 792-796, 2004.

Cui, J., Das, D., Bertelli, A., Tósaki, Á.: Effects of L-carnitine and its derivatives on postischemic cardiac function, ventricular fibrillation and necrotic and apoptotic cardiomyocyte death in isolated rat hearts.
Mol. Cell. Biochem. 254 (1-2), 227-234, 2003.

Wallukat, G., Podlowski, S., Nissen, E., Morwinski, R., Csonka, C., Tósaki, Á., Blasig, I.: Functional and structural characterization of anti-beta1-adrenoceptor autoantibodies of spontaneously hypertensive rats.
Mol. Cell Biochem. 251 (1-2), 67-75, 2003.

Bak, I., Szendrei, L., Turóczi, T., Papp, G., Joó, F., Das, D., de Leiris, J., Dér, P., Juhász, B., Varga, E., Bácskay, I., Balla, J., Kovács, P., Tósaki, Á.: Heme oxygenase-1 related carbon monoxide production and ventricular fibrillation in isolated ischemic/reperfused mouse myocardium.
Faseb J. 17 (14), 2133-2135, 2003.

Vecsernyés, M., Juhász, B., Dér, P., Kocsán, R., Fehér, P., Bácskay, I., Kovács, P., Tósaki, Á.: The administration of a-melanocyte-stimulating hormone protects the ischemic/reperfused myocardium.
Eur. J. Pharmacol. 470 (3), 177-183, 2003.

Cui, J., Juhász, B., Tósaki, Á., Maulik, N., Das, D.: Cardioprotection with grapes.
J. Cardiovasc. Pharmacol. 40 (5), 762-769, 2002.

Cui, J., Tósaki, Á., Cordis, G., Bertelli, A., Bertelli, A., Maulik, N., Das, D.: Cardioprotective abilities of white wine.
Ann. N Y Acad. Sci. 957 308-316, 2002.

Pataki, T., Bak, I., Kovács, P., Bagchi, D., Das, D., Tósaki, Á.: Grape seed proanthocyanidins improved cardiac recovery during reperfusion after ischemia in isolated rat hearts.
Am. J. Clin. Nutr. 75 (5), 894-899, 2002.

Bak, I., Papp, G., Joó, F., Tósaki, Á.: Heme oxygenase related carbon monoxide and ventricular fibrillation.
J. Mol. Cell. Cardiol. 34 (6), A6, 2002.

Szendrei, L., Turóczi, T., Kovács, P., Vecsernyés, M., Das, D., Tósaki, Á.: Mitochondrial gene expression and ventricular fibrillation in ischemic/reperfused nondiabetic and diabetic myocardium.
Biochem. Pharmacol. 63 (3), 543-552, 2002.

Cui, J., Cordis, G., Tósaki, Á., Maulik, N., Das, D.: Reduction of myocardial ischemia reperfusion injury with regular consumption of grapes.
Ann. NY Acad. Sci. 957 302-307, 2002.

Bak, I., Papp, G., Turóczi, T., Varga, E., Szendrei, L., Vecsernyés, M., Joó, F., Tósaki, Á.: The role of heme oxygenase-related carbon monoxide and ventricular fibrillation in ischemic/reperfused hearts.
Free Radic. Biol. Med. 33 (5), 639-648, 2002.

Tósaki, Á., Das, D.: The role of heme oxygenase signaling in various disorders.
Mol. Cell. Biochem. 232 (1-2), 149-157, 2002.

Bagchi, D., Das, D., Tósaki, Á., Bagchi, M., Kothari, S.: Benefits of resveratrol in women's health.
Drugs Exp. Clin. Res. 27 (5-6), 233-248, 2001.

Szolcsányi, J., Oroszi, G., Németh, J., Szilvássy, Z., Blasig, I., Tósaki, Á.: Functional and biochemical evidence for capsaicin-induced neural endothelin release in isolated working rat heart.
Eur. J. Pharmacol. 419 (2-3), 215-221, 2001.

Sato, M., Bagchi, D., Tósaki, Á., Das, D.: Grape seed proanthocyanidin reduces cardiomyocyte apoptosis by inhibiting ischemia/reperfusion-induced activation of JNK-1 and C-JUN.
Free Radic. Biol. Med. 31 (6), 729-737, 2001.

Kovács, P., Bak, I., Szendrei, L., Vecsernyés, M., Varga, E., Blasig, I., Tósaki, Á.: Non-specific caspase inhibition reduces infarct size and improves post-ischaemic recovery in isolated ischaemic/reperfused rat hearts.
Naunyn Schmiedebergs Arch. Pharmacol. 364 (6), 501-507, 2001.

Pataki, T., Bak, I., Csonka, C., Kovács, P., Varga, E., Blasig, I., Tósaki, Á.: Regulation of ventricular fibrillation by heme oxygenase in ischemic/reperfused hearts.
Antioxid. Redox Signal. 3 (1), 125-134, 2001.

Haines, D., Bak, I., Ferdinándy, P., Mahmoud, F., Al-Harbi, S., Blasig, I., Tósaki, Á.: Cardioprotective effects of the calcineurin inhibitor FK506 and the PAF receptor antagonist and free radical scavenger, EGb 761, in isolated ischemic/reperfused rat hearts.
J. Cardiovasc. Pharmacol. 35 (1), 37-44, 2000.

Kovács, P., Szilvássy, Z., Hegyi, P., Németh, J., Ferdinándy, P., Tósaki, Á.: Effect of transdermal nitroglycerin on glucose-stimulated insulin release in healthy male volunteers.
Eur. J. Clin. Invest. 30 (1), 41-44, 2000.

Csonka, C., Pataki, T., Kovács, P., Müller, S., Schroeter, M., Tósaki, Á., Blasig, I.: Effects of oxidative stress on the expression of antioxidative defense enzymes in spontaneously hypertensive rat hearts.
Free Radic. Biol. Med. 29 (7), 612-619, 2000.

Csonka, C., Szilvássy, Z., Fülöp, F., Páli, T., Blasig, I., Tósaki, Á., Schulz, R., Ferdinándy, P.: Classic preconditioning decreases the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts.
Circulation. 100 (22), 2260-2266, 1999.

Csont, T., Szilvássy, Z., Fülöp, F., Nedeianu, S., Páli, T., Tósaki, Á., Dux, L., Ferdinándy, P.: Direct myocardial anti-ischaemic effect of GTN in both nitrate-tolerant and nontolerant rats: a cyclic GMP-independent activation of KATP.
Br. J. Pharmacol. 128 (7), 1427-1434, 1999.

Szolcsányi, J., Oroszi, G., Németh, J., Szilvássy, Z., Tósaki, Á.: Endothelin release by capsaicin in isolated working rat heart.
Eur. J. Pharmacol. 376 (3), 247-250, 1999.

Csonka, C., Varga, E., Kovács, P., Ferdinándy, P., Blasig, I., Szilvássy, Z., Tósaki, Á.: Heme oxygenase and cardiac function in ischemic/reperfused rat hearts.
Free Radic. Biol. Med. 27 (1-2), 119-126, 1999.

Oroszi, G., Szilvássy, Z., Németh, J., Ferdinándy, P., Szolcsányi, J., Tósaki, Á.: Interaction between capsaicin and nitrate tolerance in isolated guinea-pig heart.
Eur. J. Pharmacol. 368 (2-3), R1-R3, 1999.

Oroszi, G., Szilvássy, Z., Németh, J., Tósaki, Á., Szolcsányi, J.: Interplay between nitric oxide and CGRP by capsaicin in isolated guinea-pig heart.
Pharmacol. Res. 40 (2), 125-128, 1999.

Varga, E., Bódi, A., Ferdinándy, P., Droy-Lefaix, M., Blasig, I., Tósaki, Á.: The protective effect of EGb 761 in isolated ischemic/reperfused rat hearts: a link between cardiac function and nitric oxide production.
J. Cardiovasc. Pharmacol. 34 (5), 711-717, 1999.

Maulik, N., Tósaki, Á., Elliott, G., Maulik, G., Das, D.: Induction of iNOS gene expression by monophosphoryl lipid A: a pharmacological approach for myocardial adaptation to ischemia.
Drugs Exp. Clin. Res. 24 (3), 117-124, 1998.

Tósaki, Á., Maulik, N., Elliott, G., Trifan, O., Popescu, L., Das, D.: Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide.
J. Pharmacol. Exp. Ther. 285 (3), 1274-1279, 1998.

Ferdinándy, P., Appelbaum, Y., Csonka, C., Blasig, I., Tósaki, Á.: Role of nitric oxide and TPEN, a potent metal chelator, in ischaemic and reperfused rat isolated hearts.
Clin. Exp. Pharmacol. Physiol. 25 (7-8), 496-502, 1998.

Tósaki, Á., Das, D.: Extracellular Mg++ manipulation prevents the proarrhythmic activity of cromakalim in ischemic/reperfused diabetic hearts.
J. Pharmacol. Exp. Ther. 282 (1), 309-317, 1997.

Tósaki, Á., Maulik, N., Cordis, G., Trifan, O., Popescu, L., Das, D.: Ischemic preconditioning triggers phospholipase D signaling in rat heart.
Am. J. Physiol. 273 (4), H1860-H1866, 1997.

Tósaki, Á., Engelman, R., Das, D.: Effects of cromakalim and glibenclamide in ischemic and reperfused hearts.
Ann. N. Y. Acad. Sci. 793 460-465, 1996.

Tósaki, Á., Pali, T., Droy-Lefaix, M.: Effects of Ginkgo biloba extract and preconditioning on the diabetic rat myocardium.
Diabetologia. 39 (11), 1255-1262, 1996.

Trifan, O., Popescu, L., Tósaki, Á., Cordis, G., Das, D.: Ischemic preconditioning involves phospholipase D.
Ann. N. Y. Acad. Sci. 793 485-488, 1996.

Nilanjana, M., Tósaki, Á., Engelman, R., Chatterjee, G., Das, D.: Lanthanum Provides Cardioprotection by Modulating Na+-Ca2+ Exchange.
Ann. N. Y. Acad. Sci. 779 546-550, 1996.

Tósaki, Á., Engelman, D., Engelman, R., Das, D.: The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts.
Cardiovasc. Res. 31 (4), 526-536, 1996.

Tósaki, Á., Maulik, N., Engelman, D., Engelman, R., Das, D.: The Role of Protein Kinase C in Ischemic/Reperfused Preconditioned Isolated Rat Hearts.
J. Cardiovasc. Pharmacol. 28 (5), 723-731, 1996.

Tósaki, Á., Engelman, D., Engelman, R., Das, D.: Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts.
J. Pharmacol. Exp. Ther. 275 (3), 1115-1123, 1995.

Tósaki, Á., Hellegouarch, A.: Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury: heart function studies in nonfibrillating isolated hearts.
J. Am. Coll. Cardiol. 23 (2), 487-496, 1994.

Tósaki, Á., Behjet, N., Engelman, D., Engelman, R., Das, D.: Alpha-1 adrenergic receptor agonist-induced preconditioning in isolated working rat hearts.
J. Pharmacol. Exp. Ther. 273 (2), 689-694, 1994.

Tósaki, Á., Cordis, G., Szerdahelyi, P., Engelman, R., Das, D.: Effects of preconditioning on reperfusion arrhythmias, myocardial functions, formation of free radicals, and ion shifts in isolated ischemic/reperfused rat hearts.
J. Cardiovasc. Pharmacol. 23 (3), 365-373, 1994.

Tósaki, Á., Engelman, R., Das, D.: Extracellular Magnesium Manipulation Reduces Reperfusion Arrhythmias and Ion Shifts in Isolated Rat Hearts.
Ann. N. Y. Acad. Sci. 723 385-388, 1994.

Tósaki, Á., Engelman, D., Pali, T., Engelman, R., Droy-Lefaix, M.: Ginkgo biloba extract (EGb 761) improves postischemic function in isolated preconditioned working rat hearts.
Coronary Artery Dis. 5 (5), 443-450, 1994.

Maulik, N., Tósaki, Á., Engelman, R., Cordis, G., Das, D.: Myocardial salvage by 1-O-hexadecyl-Sn-glycerol: possible role of peroxisomal dysfunction in ischemia reperfusion injury.
J. Cardiovasc. Pharmacol. 24 (3), 486-492, 1994.

Maulik, N., Tósaki, Á., Engelman, R., Cordis, G., Das, D.: Myocardial salvage by chimyl alcohol: possible role of peroxisomal dysfunction in reperfusion injury.
Ann. N. Y. Acad. Sci. 723 380-384, 1994.

Tósaki, Á., Das, D.: Reperfusion induced arrhythmias are caused by generation of free radicals.
Cardiovasc. Res. 28 (3), 422, 1994.

Tósaki, Á., Szerdahelyi, P., Joó, F.: Treatment with ranitidine of ischemic brain edema.
Eur. J. Pharmacol. 264 (3), 455-458, 1994.

Tósaki, Á., Bagchi, D., Pali, T., Cordis, G., Das, D.: Comparisons of ESR and HPLC methods for the detection of OH. radicals in ischemic/reperfused hearts. A relationship between the genesis of free radicals and reperfusion arrhythmias.
Biochem. Pharmacol. 45 (4), 961-969, 1993.

Tósaki, Á., Szerdahelyi, P., Engelman, R., Das, D.: Effects of extracellular magnesium manipulation on reperfusion-induced arrhythmias and myocardial ion shifts in isolated ischemic reperfused rat hearts.
J. Pharmacol. Exp. Ther. 267 (3), 1045-1053, 1993.

Tósaki, Á., Droy-Lefaix, M., Pali, T., Das, D.: Effects of SOD, catalase, and a novel antiarrhythmic drug, EGB 761, on reperfusion-induced arrhythmias in isolated rat hearts.
Free Radic. Biol. Med. 14 (4), 361-370, 1993.

Ferdinándy, P., Das, D., Tósaki, Á.: Pacing-induced Ventricular Fibrillation Leading to Oxygen Free Radical Formation in Aerobically Perfused Rat Hearts.
J. Mol. Cell. Cardiol. 25 (6), 683-692, 1993.

Tósaki, Á., Szerdahelyi, P., Engelman, R., Das, D.: Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?.
J. Pharmacol. Exp. Ther. 267 (3), 1355-1362, 1993.

Szekeres, L., Tósaki, Á.: Release of 6-keto-PGF1 alpha and thromboxane B2 in late appearing cardioprotection induced by the stable PGI analogue: 7-OXO-PGI.
Mol. Cell. Biochem. 119 (1-2), 129-132, 1993.

Abrahám, C., Koltai, M., Joó, F., Tósaki, Á., Szerdahelyi, P.: Adrenalectomy aggravates ischemic brain edema in female Sprague-Dawley rats with carotid arteries ligated.
Prog. Brain Res. 91 23-27, 1992.

Ferdinándy, P., Koltai, M., Tósaki, Á., Berthet, P., Tarrade, T., Esanu, A., Braquet, P.: Cicletanine improves myocardial function deteriorated by ischemia/reperfusion in isolated working rat hearts.
J. Cardiovasc. Pharmacol. 19 (2), 181-189, 1992.

Tósaki, Á., Haseloff, R., Hellegouarch, A., Schoenheit, K., Martin, V., Das, D., Blasig, I.: Does the antiarrhythmic effect of DMPO originate from its oxygen radical trapping property or the structure of the molecule itself?.
Basic Res. Cardiol. 87 (6), 536-547, 1992.

Koltai, M., Tósaki, Á., Berthet, P., Tarrade, T., Esanu, A., Braquet, P.: Effect of cicletanine on reperfusion-induced arrhythmias and myocardial ion contents: a comparison with furosemid.
Eur. Heart J. 13 (3), 395-403, 1992.

Tósaki, Á., Szerdahelyi, P., Das, D.: Reperfusion-induced arrhythmias and myocardial ion shifts: a pharmacologic interaction between pinacidil and cicletanine in isolated rat hearts.
Basic Res. Cardiol. 82 (4), 366-384, 1992.

Liu, X., Tósaki, Á., Engleman, R., Das, D.: Salicylate Reduces Ventricular Dysfunction and Arrhythmias During Reperfusion in Isolated Rat Hearts.
J. Cardiovasc. Pharmacol. 19 (2), 209-215, 1992.

Koltai, M., Tósaki, Á., Tarrade, T., Berthet, P., Esanu, A., Braquet, P.: Cicletanine: a novel approach to cardioprotection in spontaneously hypertensive rats.
Coronary Artery Dis. 2 941-944, 1991.

Tósaki, Á., Hellegouarch, A., Braquet, P.: Cicletanine and reperfusion injury: is there any correlation between arrhythmias, 6-keto-PGF1 alpha, thromboxane B2, and myocardial ion shifts (Na+, K+, Ca2+, and Mg2+) induced by ischemia/reperfusion in isolated rat heart.
J. Cardiovasc. Pharmacol. 17 (4), 551-559, 1991.

Koltai, M., Tósaki, Á., Hosford, D., Esanu, A., Braquet, P.: Effect of BN 50739, a new platelet activating factor antagonist, on ischaemia induced ventricular arrhythmias in isolated working rat hearts.
Cardiovasc. Res. 25 (5), 391-397, 1991.

Tósaki, Á., Viossat, I., Braquet, P.: Effect of cicletanine on reperfusion-induced arrhythmias and its relation to 6-keto-PGF1 alpha and thromboxane B2 release.
J. Can. Pet. Technol. 69 (4), 488-493, 1991.

Szekeres, L., Bálint, Z., Karcsu, S., Tósaki, Á.: Delayed protection by oxo-7-PGI2 against cardiac transmembrance ion shipfts and early morphological changes due to ischemia and reperfusion.
Cardioscience. 1 (4), 279-286, 1990.

Tósaki, Á., Braquet, P.: DMPO and reperfusion injura: arrhythmia, heart function, electron spin resonance, and nuclear magnetic resonance studies in isolated working guinea pig hearts.
Am. Heart J. 120 (4), 819-830, 1990.

Tósaki, Á., Koltai, M., Willoughby, D., Braquet, P.: Effect of Cicletanine on Reperfusion-Induced Arrhythmias and Ion Shifts in Isolated Rat Hearts.
J. Cardiovasc. Pharmacol. 15 (2), 218-226, 1990.

Tósaki, Á., Koltai, M., Paubert-Braquet, M.: Effect of iloprost on reperfusion-induced arrhythmias and myocardial ion shifts in isolated rat hearts.
Eur. J. Pharmacol. 191 (1), 69-81, 1990.

Tósaki, Á., Blasig, I., Pali, T., Ebert, B.: Heart protection and radical trapping by DMPO during reperfusion in isolated working rat hearts.
Free Radic. Biol. Med. 8 (4), 363-372, 1990.

Blasig, I., Ebert, B., Hennig, C., Pali, T., Tósaki, Á.: Inverse relationship between ESR spin trapping of oxyradicals and degree of functional recovery during myocardial reperfusion in isolated working rat heart.
Cardiovasc. Res. 24 (4), 263-270, 1990.

Tósaki, Á., Woodward, B., Yamamoto, F., Hearse, D.: Isoproterenol and the genesis of reperfusion-induced arrhythmias in isolated rat heart: adrenoceptor or free radical-mediated mechanisms?.
J. Cardiovasc. Pharmacol. 15 (3), 398-407, 1990.

Tósaki, Á., Koltai, M., Braquet, P.: Effects of low extracellular sodium concentration on reperfusion induced arrhythmias: changes in the myocardial sodium, potassium and calcium contents in isolated guinea pig hearts.
Cardiovasc. Res. 23 (12), 993-1000, 1989.

Tósaki, Á., Guillon, J., Koltai, M., Braquet, P.: Effet du cicletanine sur les arythmies et 1'accumulation intracellulaire du sodium du coeur isole de rat au cours de I'ischemie et de la reperfusion = Effect of cicletanine on arrhythmia and intracellular sodium accumulation in the isolated rat heart during ischemia and reperfusion.
Arh. Mal. Coeur. Vaiss. 82 (4), 155-161, 1989.

Koltai, M., Tósaki, Á., Hosford, D., Braquet, P.: Ginkgolide B protects isolated hearts against arrhythmias induced by ischemia but not reperfusion.
Eur. J. Pharmacol. 164 (2), 293-302, 1989.

Joó, F., Tósaki, Á., Oláh, Z., Koltai, M.: Inhibition by H-7 of the protein kinase C prevents formation of brain edema in Sprague-Dawley CFY rats.
Brain Res. 490 (1), 141-143, 1989.

Koltai, M., Tósaki, Á., Guillon, J., Hosford, D., Braquet, P.: PAF antagonists as potential therapeutic agents in cardiac anaphylaxis and myocardial ischemia.
Cardiovasc. Drug Rev. 7 (3), 177-198, 1989.

Tósaki, Á., Koltai, M., Braquet, P., Szekeres, L.: Possible involvement of platelet activating factor in anaphylaxis of passively sensitised, isolated guinea pig hearts.
Cardiovasc. Res. 23 (8), 715-22, 1989.

Tósaki, Á., Hearse, D.: Fluoro-fatty acids and the impairment of cardiac function in the rat in vivo and in vitro.
Basic Res. Cardiol. 83 (2), 158-166, 1988.

Hearse, D., Tósaki, Á.: Free radicals and calcium: simultaneous interacting triggers as determinants of vulnerability to reperfusion-induced arrhythmias in the rat heart.
J. Mol. Cell. Cardiol. 20 (3), 213-223, 1988.

Tósaki, Á., Bálint, Z., Szekeres, L.: Pacing and reperfusion induced arrhythmias: protection by slow heart rate in the rat heart.
Cardiovasc. Res. 22 (11), 818-825, 1988.

Tósaki, Á., Bálint, Z., Szekeres, L.: Protective effect of lidocaine against ischemia and reperfusion-induced arrhythmias and shifts of myocardial sodium, potassium, and calcium content.
J. Cardiovasc. Pharmacol. 12 (6), 621-628, 1988.

Tósaki, Á., Szekeres, L., Hearse, D.: Diltiazem and the reduction of reperfusion-induced arrhythmias in the rat: protection is secondary to modification of ischemic injury and heart rate.
J. Mol. Cell. Cardiol. 19 (5), 441-451, 1987.

Hearse, D., Tósaki, Á.: Free radicals and reperfusion-induced arrhytmias: protection by spin trap agent PBN in the rat heart.
Circ. Res. 60 (3), 375-383, 1987.

Szekeres, L., Bálint, Z., Tósaki, Á.: Ion shifts in myocardial cells during ischemia and reperfusion and the effect of membrane stabilizing agents on ischemic ion transport.
Biomed. Biochim. Acta. 46 (8-9), S527-S533, 1987.

Tósaki, Á., Szekeres, L., Hearse, D.: Metoprolol reduces reperfusion-induced fibrillation in the isolated rat heart: protection is secondary to bradycardia.
J. Cardiovasc. Pharmacol. 10 (5), 489-497, 1987.

Tósaki, Á., Hearse, D.: Protective effect of transient calcium reduction against reperfusion-induced arrhythmias in rat hearts.
Am. J. Physiol. 253 (2PT2), H225-H233, 1987.

Hearse, D., Tósaki, Á.: Reperfusion-Induced Arrhythmias and Free Radicals: studies in the Rat Heart with DMPO.
J. Cardiovasc. Pharmacol. 9 (6), 641-650, 1987.

Blasig, I., Bor, P., Tósaki, Á., Szekeres, L., Löwe, H.: Effect of activated oxygen species on mitochondria isolated from myocardium after reperfusion injury.
Gen. Physiol. Biophys. 5 (6), 655-658, 1986.

Koltai, M., Tósaki, Á., Leprán, I., Szekeres, L.: Glucocorticoids in myocardial and cerebral infarction.
Agents Actions. 17 (3-4), 278-283, 1986.

Tósaki, Á., Koltai, M., Joó, F., Ádám, G., Szerdahelyi, P., Leprán, I., Takáts, I., Szekeres, L.: Actinomycin D suppresses the protective effect of dexamethasone in rats affected by global cerebral ischemia.
Stroke. 16 (3), 501-505, 1985.

Koltai, M., Tósaki, Á., Ádám, G., Joó, F., Nemecz, G., Szekeres, L.: Prevention by macrocortin of global cerebral ischemia in Sprague-Dawley rats.
Eur. J. Pharmacol. 105 (3-4), 347-350, 1984.